Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

C87414 Inhibitors

Chemical inhibitors of C87414 include a range of compounds that target different kinases and enzymes involved in signaling pathways that C87414 is part of. Wortmannin and LY294002 are two such inhibitors that target phosphoinositide 3-kinases (PI3K), essential components of the PI3K/AKT pathway where C87414 functions. By inhibiting PI3K, these chemicals prevent the phosphorylation and activation of AKT, leading to a decrease in the downstream signaling activities, including those involving C87414. Rapamycin targets mTOR, another significant kinase in the AKT pathway, and its inhibition suppresses mTORC1 and mTORC2 complexes that are crucial for various cellular processes, thereby inhibiting the functional activity of C87414. Similarly, Palbociclib's inhibition of CDK4/6 affects the cell cycle and can alter the functions of C87414 if it is involved in cell cycle regulation.

In addition to these, Trametinib and U0126 target the MAPK/ERK pathway by inhibiting MEK1/2. This pathway is critical for cell proliferation and survival, and C87414's role, if any, in this pathway would be inhibited as a result of decreased ERK activation. SP600125 and SB203580 inhibit the JNK and p38 MAPK pathways, respectively. These pathways are involved in stress response and inflammation, and by inhibiting these kinases, the chemicals can disrupt functions where C87414 is implicated. ZM-447439 and Alsterpaullone work by inhibiting Aurora kinases and CDKs, affecting cell cycle progression where C87414 may play a role. PD98059 also inhibits MEK, similar to Trametinib and U0126, leading to a decrease in C87414 functional activity through reduced ERK activation. Lastly, PP2 targets Src family kinases, which regulate various signaling pathways, including those involving C87414, and its inhibition can lead to a decrease in the functional activity of C87414. Each of these chemicals, by targeting specific kinases or enzymes, leads to the functional inhibition of C87414 through the disruption of the signaling pathways and cellular processes that C87414 is known to be involved in.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K which is upstream of AKT signaling; since C87414 is part of AKT signaling, PI3K inhibition leads to reduced AKT activation and thereby inhibits C87414 functional activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, thus preventing the activation of AKT and subsequent downstream proteins including C87414, leading to its functional inhibition.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, a key kinase downstream of PI3K/AKT pathway; mTOR inhibition can suppress downstream signaling affecting C87414 activity.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Inhibits CDK4/6 which are involved in cell cycle progression; inhibition of these kinases can alter cell cycle-related functions where C87414 may play a role, thus inhibiting its function.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

Inhibits MEK, part of the MAPK/ERK pathway; as C87414 is involved in this pathway, MEK inhibition can lead to reduced ERK activation and a consequent decrease in C87414 functional activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Selectively inhibits MEK1/2, impacting the MAPK/ERK pathway and thereby inhibiting the functional activity of C87414 which is part of this signaling cascade.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, which is involved in stress and inflammatory responses; JNK inhibition can disrupt functions where C87414 is implicated, leading to its functional inhibition.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAPK, affecting the p38 MAPK pathway; since C87414 operates within this pathway, its functional activity is inhibited as a result.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

Inhibits Aurora kinases, which play a role in cell cycle progression; inhibition of these kinases can affect processes involving C87414, leading to its functional inhibition.

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$68.00
$312.00
2
(1)

Inhibits CDKs, particularly CDK1/cyclin B, which are critical for cell cycle progression; inhibition of these kinases can impair C87414 function which may be associated with the cell cycle.